BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors
Clinical trial NCT04819373 · COMPLETED
Trial details
- NCT number
- NCT04819373
- Sponsor
- Eikon Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-04-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.